Publication | Open Access

Benefit of high-dose methylprednisolone in comparison with conventional-dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-term follow-up

Hematological MalignancyLymphoid NeoplasiaHigh-dose MethylprednisoloneMedicinePediatric HematologyHematologyPediatricsConventional-dose PrednisoloneAdult T-cell Leukemia-lymphomaOncologyLong-term Follow-up